1 – 10 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Direct Reprogramming of Mouse and Human Fibroblasts into Conventional Dendritic Cells Type 1
(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Human antibody technology and the development of antibodies against cytomegalovirus.
(
- Contribution to journal › Scientific review
-
Mark
Classical pathway deficiencies - A short analytical review.
(
- Contribution to journal › Scientific review
-
Mark
Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation.
(
- Contribution to journal › Article
-
Mark
European Union funded project on the development of a whole complement deficiency screening ELISA-A story of success and an exceptional manager: Mohamed R. Daha.
(
- Contribution to journal › Scientific review
-
Mark
Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.
(
- Contribution to journal › Article
- 2014
-
Mark
A new look at a poorly immunogenic neutralization epitope on cytomegalovirus glycoprotein B. Is there cause for antigen redesign?
(
- Contribution to journal › Article
- 2013
-
Mark
Human complement control and complement evasion by pathogenic microbes - Tipping the balance
(
- Contribution to journal › Scientific review
- 2012
-
Mark
Multiple domains of MASP-2, an initiating complement protease, are required for interaction with its substrate C4
(
- Contribution to journal › Article
-
Mark
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases.
(
- Contribution to journal › Article